IDT Biologika buys vax plant from Aeras; Biogen reaches carbon neutrality; Merck tries data mining

> IDT Biologika has formed a partnership with nonprofit TB vaccine vaccine developer Aeras that includes it buying an Aeras manufacturing plant in the U.S. Release

> BioNTech AG has contracted with Siemens to build a paperless manufacturing plant for its cancer vaccine therapies. Release

> German restructuring firm Mutares AG has sold CMO Suir Pharma Ireland to the strategic investor Saneca Pharmaceuticals. Release

> Vin Nguyen of Corona, CA, has pleaded guilty to federal charges that he and others sold back into the legitimate supply chain $6.5 million in prescription meds that they had bought illegally. Release

> Investing in more energy efficient manufacturing facilities has helped biotech Biogen ($BIIB) to attain carbon neutrality. Release

> Merck ($MRK) has turned to data mining company Enigma to help it focus its supply chain and manufacturing operations, particularly in relation to public tender demand. Story

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.